Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025

Audio By Carbonatix

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Oct 14, 2025--

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2025 of $1.30 per share on the company’s common stock. The dividend is payable on December 9, 2025 to shareholders of record at the close of business on November 25, 2025. The ex-dividend date is November 25, 2025.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251014059893/en/

CONTACT: Media contact:

[email protected] contact:

[email protected]

KEYWORD: NEW JERSEY UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH PHARMACEUTICAL HEALTH

SOURCE: Johnson & Johnson

Copyright Business Wire 2025.

PUB: 10/14/2025 06:30 AM/DISC: 10/14/2025 06:29 AM

http://www.businesswire.com/news/home/20251014059893/en